At the Gynecology and Obstetrics Clinic of the VFN and the 1st LV of the UK, patients will start treatment within two days. At the same time, they and their family members will also undergo genetic examinations.

Every year in the Czech Republic, almost 1,000 women fall ill with ovarian cancer. Unfortunately, 300 of them will never find out if the BRCA gene mutation was the cause of their disease. In doing so, one genetic examination is enough, and the health and lives of women in the family line can be saved. Specialists in the Oncology Center of the Gynecology and Obstetrics Clinic of the VFN and the 1st Faculty of Medicine of the University of Warsaw perform not only detailed sonographic diagnostics, but are able to start treatment within two days, which can reverse the poor prognosis of the disease in some patients.

A genetic mutation in one of the BRCA genes causes up to a 30x higher risk of ovarian cancer and a 10x higher risk of breast cancer in women. An increased predisposition to cancer does not escape men either, roughly one in 750 Czechs carries the genetic disorder. "Carriers and carriers of genetic disorders, such as the BRCA gene mutation, can either completely avoid the disease thanks to preventive operations, or have a better chance of early detection thanks to regular monitoring. But it has one condition. They have to know for themselves that something is wrong with their genes, that is, find out their BRCA status,” prof. MD David Cibula, CSc., head of the Gynecology and Obstetrics Clinic of the 1st Faculty of Medicine of the UK and VFN in Prague
and adds: "That's why it's so crucial that no woman with ovarian cancer misses a genetic test and, in the case of a positive test, direct relatives are tested for the presence of mutations." Despite all the efforts to educate the public and spread information about the possibilities of genetic testing, for example by the Apolinář Foundation and the patient organization VERONICA, more than a quarter of ovarian cancer patients still remain without genetic testing.

More information can be found in press release.